Cargando…

Virological Outcomes and Drug Resistance in Chinese Patients after 12 Months of 3TC-Based First-Line Antiretroviral Treatment, 2011–2012

OBJECTIVE: To determine the prevalence of virological failure and HIV drug resistance among Chinese patients one year after initiating lamivudine-based first-line antiretroviral treatment. METHODS: A prospective cohort study with follow-up at 12 months was conducted in four urban sentinel sites in C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jing, He, Cui, Hsi, Jenny H., Xu, Xiaoqin, Liu, Yong, He, Jianmei, Ling, Hua, Ding, Ping, Tong, Yi, Zou, Xiaobai, Zhou, Quanhua, Liao, Lingjie, Wang, Xia, Ruan, Yuhua, Shao, Yiming, Xing, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917868/ https://www.ncbi.nlm.nih.gov/pubmed/24516631 http://dx.doi.org/10.1371/journal.pone.0088305

Ejemplares similares

Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008–2012: a prospective cohort study
por: Kan, Wei, et al.
Publicado: (2017)

Adherence, virological outcome, and drug resistance in Chinese HIV patients receiving first-line antiretroviral therapy from 2011 to 2015
por: Liu, Pengtao, et al.
Publicado: (2018)

Incidence and Associated Factors of HIV Drug Resistance in Chinese HIV-Infected Patients Receiving Antiretroviral Treatment
por: Xing, Hui, et al.
Publicado: (2013)

Impact of HIV Pretreatment Drug Resistance on Virological Failure After One-Year Antiretroviral Therapy — China, 2018–2019
por: Li, Miaomiao, et al.
Publicado: (2022)

Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China
por: Liao, Lingjie, et al.
Publicado: (2013)

HIV virological failure and drug resistance among injecting drug users receiving first-line ART in China
por: Leng, Xuebing, et al.
Publicado: (2014)

Prevalence of acquired drug resistance mutations in antiretroviral- experiencing subjects from 2012 to 2017 in Hunan Province of central South China
por: Zou, Xiaobai, et al.
Publicado: (2020)

Lamivudine Concentration in Hair and Prediction of Virologic Failure and Drug Resistance among HIV Patients Receiving Free ART in China
por: Yan, Jing, et al.
Publicado: (2016)

Drug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of China
por: Zuo, Zhongbao, et al.
Publicado: (2016)

HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China
por: Chen, Xi, et al.
Publicado: (2016)

Relationship Between Drug Resistance and Death in HIV-Infected Patients Receiving Antiretroviral Therapy — 7 PLADs, China, 2010−2019
por: Zhang, Tianhao, et al.
Publicado: (2021)

Molecular transmission network of pretreatment drug resistance among human immunodeficiency virus-positive individuals and the impact of virological failure on those who received antiretroviral therapy in China
por: Chen, Hongli, et al.
Publicado: (2022)

Higher Risk of Mortality and Virologic Failure in HIV-Infected Patients With High Viral Load at Antiretroviral Therapy Initiation: An Observational Cohort Study in Chongqing, China
por: Zhou, Chao, et al.
Publicado: (2022)

Nationwide Cohort Study of Antiretroviral Therapy Timing: Treatment Dropout and Virological Failure in China, 2011–2015
por: Zhao, Yan, et al.
Publicado: (2019)

Correction: Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008–2012: a prospective cohort study
Publicado: (2018)

Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy
por: Kerschberger, Bernhard, et al.
Publicado: (2015)

Treatment outcomes and HIV drug resistance of patients switching to second-line regimens after long-term first-line antiretroviral therapy: An observational cohort study
por: Cao, Pi, et al.
Publicado: (2018)

Thank you to Virology Journal’s peer reviewers in 2012
por: Wang, Linfa
Publicado: (2013)

Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naïve Subjects in Hunan Province, China
por: Xiaobai, Zou, et al.
Publicado: (2014)

Low Virologic Failure and Drug Resistance among HIV-Infected Patients Receiving Hospital-Based ART While Care and Outreach through Community in Guangxi, China
por: Liang, Shujia, et al.
Publicado: (2015)

Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China
por: Liu, Pengtao, et al.
Publicado: (2022)

2011–2012 Reviewers
Publicado: (2013)

2011–2012 Reviewers
Publicado: (2013)

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months’ antiretroviral therapy experience in Cameroon
por: Aghokeng, Avelin F, et al.
Publicado: (2013)

The sexually driven epidemic in youths in China’s southwestern border region was caused by dynamic emerging multiple recombinant HIV-1 strains
por: Wei, Huamian, et al.
Publicado: (2015)

Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
por: Abdissa, Alemseged, et al.
Publicado: (2014)

Pregnancy and Virologic Response to Antiretroviral Therapy in South Africa
por: Westreich, Daniel, et al.
Publicado: (2011)

The LHCb trigger in 2011 and 2012
por: Puig, Albert
Publicado: (2014)

Primera Sala 2011-2012 /
Publicado: (2017)

CMS collaboration 2011 , 2012
por: Hoch, Michael
Publicado: (2012)

HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in China
por: Li, Miaomiao, et al.
Publicado: (2021)

Treatment outcomes of initial differential antiretroviral regimens among HIV patients in Southwest China: comparison from an observational cohort study
por: Kang, Ruihua, et al.
Publicado: (2019)

Effects of HIV-1 genotype on baseline CD4+ cell count and mortality before and after antiretroviral therapy
por: Cao, Zhiqiang, et al.
Publicado: (2020)

Early antiretroviral therapy on reducing HIV transmission in China: strengths, weaknesses and next focus of the program
por: Liu, Pengtao, et al.
Publicado: (2018)

Prevalence of Transmitted HIV drug resistance in antiretroviral treatment naïve newly diagnosed individuals in China
por: Zhao, Shuai, et al.
Publicado: (2018)

Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997–2011
por: Martin, David A, et al.
Publicado: (2014)

HIV transmission and associated factors under the scale-up of HIV antiretroviral therapy: a population-based longitudinal molecular network study
por: Chen, Yi, et al.
Publicado: (2023)

Epidemiological and Virological Characteristics of Influenza in Chongqing, China, 2011-2015
por: Qi, Li, et al.
Publicado: (2016)

Outcomes of initial antiretroviral treatment (ART) among recently diagnosed HIV patients in HIV-TR cohort, 2011–2012
por: Korten, Volkan, et al.
Publicado: (2014)

Cross-sectional study of virological failure and multinucleoside reverse transcriptase inhibitor resistance at 12 months of antiretroviral therapy in Western India
por: Karade, Santosh K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lhcjdvuqltg0snoln2s39d6u4h